These total results claim that CUDC-101, using its synergistic inhibitions of multiple pathways, gets the potential to improve the response prices and prolong the duration of response in comparison with traditional kinase inhibitors.. Biological activity of Curis’ CUDC-101 HDAC, EGFR and HER2 inhibitor posted in Cancer Research Curis, Inc. , a drug development business wanting to develop next era targeted small molecule medication candidates for tumor treatment, today announced a analysis paper describing the biological activity of its HDAC, HER2 and EGFR inhibitor, CUDC-101, was published on-line in the journal Cancers Research and in addition will be published within an upcoming print edition of the journal.In 2012, the International Herald Tribune [now the International NY Times] ran an article titled Garlic inhibits TB bacteria, finds research. The article stated: Garlic is already known for its anti-tumour, anti-hyperlidemic and anti-microbial properties. Allicin is the compound in garlic that provides it its pungent smell as well as its powerful health benefits. A mere 1 milligram of allicin is 15 times as potent as penicillin nearly. Allicin offers a wide spectrum of safety against pathogenic bacteria, viruses and parasites.